LIVE

Serial Number

97248094

Owner

Enanta Pharmaceuticals, Inc.

Attorney

Joshua S. Jarvis, Esq.

First Use Date

Aug 9, 2024

Filing Date

Feb 1, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

Serial #97248094 Trademark

Serial Number: 97248094 • Registration: 7663230

Serial #97248094 is a trademark filed by Enanta Pharmaceuticals, Inc. on February 1, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Enanta Pharmaceuticals, Inc. (6 trademarks)

750 Main Street
Cambridge, MA 02139

Entity Type: 03

Legal Representation

Attorney of Record

Joshua S. Jarvis, Esq.

648 trademarks filed View all →

Correspondence Address

Joshua S. Jarvis, Esq. FOLEY HOAG LLP

155 SEAPORT BOULEVARD

BOSTON, MA 02210

United States

Trademark Details

Filing Date

February 1, 2022

Registration Date

January 21, 2025

First Use Anywhere

August 9, 2024

First Use in Commerce

August 9, 2024

Published for Opposition

December 27, 2022

Goods & Services

Pharmaceutical preparations for the treatment of viral infections and hepatic diseases and disorders

Research and development services in the field of identification of compounds as potential therapeutic products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 21, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Jan 21, 2025 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 31, 2024 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 31, 2024 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 17, 2024 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 17, 2024 AITU

USE AMENDMENT FILED

Aug 13, 2024 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 13, 2024 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 6, 2024 EXRA

SOU EXTENSION 3 GRANTED

Aug 6, 2024 EX3G

SOU EXTENSION 3 FILED

Aug 6, 2024 EXT3

SOU TEAS EXTENSION RECEIVED

Aug 6, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 14, 2024 EXRA

SOU EXTENSION 2 GRANTED

Feb 13, 2024 EX2G

SOU EXTENSION 2 FILED

Feb 13, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Feb 13, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 18, 2023 EXRA

SOU EXTENSION 1 GRANTED

Aug 16, 2023 EX1G

SOU EXTENSION 1 FILED

Aug 16, 2023 EXT1

SOU TEAS EXTENSION RECEIVED

Aug 16, 2023 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 21, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 27, 2022 NPUB

PUBLISHED FOR OPPOSITION

Dec 27, 2022 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 7, 2022 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 18, 2022 CNSA

ASSIGNED TO EXAMINER

Nov 14, 2022 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Feb 8, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 7, 2022 NWOS

NEW APPLICATION ENTERED

Feb 4, 2022 NWAP

Related Trademarks

More from this Owner

GREAT CHEMISTRY CURES

ENANTA PHARMACEUTICALS

More in Same Class

VIZIFY

Serial #79345478

SPREADPOWER

Serial #79339492

EQUABELLE

3D IPNS TECHNOLOGY